التفاصيل البيبلوغرافية
| العنوان: |
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer. |
| المؤلفون: |
Carneiro, BA, Ramanathan, RK, Fakih, MG, Krishnamurthi, SS, Lembersky, BC, Stoller, RG, Lancaster, SL, Pinkerton, RA, Crandall, TL, Schmotzer, AR, Potter, DM, Bahary, N, Carneiro, Benedito A, Ramanathan, Ramesh K, Fakih, Marwan G, Krishnamurthi, Smitha S, Lembersky, Barry C, Stoller, Ronald G, Lancaster, Stewart L, Pinkerton, Richard A |
| المصدر: |
Clinical Colorectal Cancer; 2012 Mar, Vol. 11 Issue 1, p53-59, 7p |
| قاعدة البيانات: |
Complementary Index |
